# HEPION PHARMACEUTICALS INC (HEPA)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/HEPA/

- Reporting holders: 1
- Reported value: $0
- Shares held by institutions: 1 of 90,219,317 outstanding

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Ancora Advisors LLC](https://holderbook.com/funds/1446114-ancora-advisors-llc/) | $0 | 1 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q2 2025 | 1 | $1.4K |
| Q1 2025 | 13 | $419.7K |
| Q4 2024 | 18 | $215.4K |
| Q3 2024 | 22 | $338.2K |
| Q2 2024 | 23 | $863.9K |
| Q1 2024 | 22 | $1.8M |
| Q4 2023 | 22 | $2.4M |
| Q3 2023 | 22 | $4.0M |
| Q2 2023 | 22 | $5.5M |
| Q1 2023 | 31 | $5.7M |
| Q4 2022 | 29 | $2.2M |